7p15.2 (near HOXA10/HOXA11)

The 7p15.2 Locus — A Regulatory Variant Near Genes That Shape the Uterus

Endometriosis — in which tissue resembling the uterine lining grows outside the uterus — affects
an estimated 10% of women of reproductive age and accounts for a significant share of chronic
pelvic pain and infertility. Despite its prevalence, most cases take
4 to 11 years to diagnose | Diagnosis requires laparoscopy to confirm; symptoms are often
normalized or attributed to primary dysmenorrhea.
Roughly half of endometriosis susceptibility is heritable. rs12700667 is one of the strongest
and most replicated common genetic risk signals yet discovered for the disease.

The variant sits in an intergenic region on chromosome 7p15.2 — between protein-coding genes —
approximately 331 kilobases upstream of NFE2L3 (a transcription factor implicated in
inflammation and cell differentiation) and roughly 1.35 megabases from the
HOXA10 and HOXA11 homeobox genes | Homeobox genes encode transcription factors that
control body plan patterning; in adults, HOXA10 and HOXA11 continue to regulate endometrial
development and receptivity.
Intergenic variants at this distance can still influence gene expression by altering
long-range chromatin interactions and enhancer activity.

The Mechanism

HOXA10 and HOXA11 are essential transcription factors for the development of the Müllerian
ducts into the uterus and are dynamically regulated by estrogen and progesterone throughout the
menstrual cycle. Their expression peaks during the mid-secretory phase — the implantation
window — where they coordinate endometrial stromal decidualization, immune modulation, and
epithelial receptivity. In women with endometriosis, HOXA10 expression is consistently
reduced in the eutopic endometrium:
this downregulation stems from a combination of epigenetic hypermethylation and chronic
inflammatory signals generated by ectopic implants | Reduced HOXA10 in the endometrium
impairs decidualization and uterine receptivity, contributing to the infertility associated
with endometriosis.

The rs12700667 locus may act as a regulatory element that influences baseline transcriptional
activity of these HOX genes. Carrying the A risk allele could subtly alter enhancer
interactions with the HOXA cluster, lowering the threshold for endometrial dysfunction and
ectopic implant establishment. Functional studies to confirm this mechanism are ongoing;
the locus also contains a microRNA (hsa-mir-148a) and non-coding RNA transcripts that
may independently contribute.

The Evidence

The initial discovery came from a
genome-wide association study of 3,194 surgically confirmed endometriosis cases and 7,060
controls from Australia and the UK, subsequently replicated in a US cohort | Painter et al.
Nature Genetics, 2011.
The combined dataset of 5,586 cases and 9,331 controls reached genome-wide significance
(P = 1.4 × 10⁻⁹). The odds ratio for any endometriosis was 1.20 (95% CI 1.13–1.27), rising
to 1.38 (95% CI 1.24–1.53, P = 1.5 × 10⁻⁹) for moderate-to-severe disease (Stage III/IV).

A subsequent meta-analysis of eight GWAS datasets | Rahmioglu et al. Human Reproduction Update,
2014 across European and Japanese populations
confirmed the association with consistent directional effect and no significant heterogeneity:
OR 1.13 for all endometriosis (P = 1.6 × 10⁻⁹) and OR 1.22 for stage III/IV enriched
samples (P = 4.2 × 10⁻¹¹). The risk allele A is common in European populations (frequency
approximately 0.74), so most women carry at least one copy — but homozygosity approximately
doubles the additional risk compared to heterozygosity.

The effect is notably stronger for advanced disease. Five of the six replicated endometriosis
loci, including 7p15.2, show larger odds ratios when restricted to Stage III/IV cases.
In Polish women with endometriosis and infertility specifically, the odds ratio for severe
stages reached 1.39 | Szczepańska et al. Arch Med Sci, 2018.
The variant has replicated in East Asian (Japanese and Chinese) cohorts, demonstrating
cross-ethnic generalizability despite very different A allele frequencies in those populations
(~0.18 in East Asians).

Practical Implications

Carrying the A allele at rs12700667 raises the population-level probability of developing
endometriosis. The absolute risk conferred by a single common variant of moderate effect
is modest, but the biological pathway implicated — HOX gene regulation and endometrial
development — points to concrete clinical surveillance strategies.

The most actionable implication is awareness of early symptoms and willingness to escalate
to specialist evaluation. Dysmenorrhea that disrupts daily function, deep dyspareunia,
cyclic bowel or bladder symptoms, and chronic pelvic pain are all cardinal presentations.
Because endometriosis can only be definitively confirmed by laparoscopy, many cases are
managed presumptively based on clinical presentation and ultrasound — a gynecologist with
endometriosis expertise can guide the diagnostic pathway without immediately requiring surgery.

For A/A homozygotes, the modestly elevated risk is worth factoring into family planning
discussions and fertility workup timing. Endometriosis-associated infertility can be treated
with excision surgery, medical suppression, or assisted reproduction, but earlier diagnosis
generally allows more options and less disease progression.

Interactions

rs7521902 (near WNT4): WNT4 encodes a signaling protein that suppresses androgen
production and supports normal female reproductive development. The rs7521902 locus is one
of the most strongly replicated endometriosis GWAS hits (P = 1.8 × 10⁻¹⁵ in large
meta-analyses) and has also been linked to PCOS susceptibility through opposing effects
on androgen signaling. Carrying risk alleles at both 7p15.2 and WNT4 loci may confer
additive endometriosis susceptibility, though formal interaction testing across both variants
has not yet been published.

rs1250248 (FN1 — fibronectin 1): An epistatic interaction between rs7521902 (WNT4)
and rs1250248 (FN1) has been described specifically for ovarian endometriosis. Fibronectin
is a major extracellular matrix protein implicated in cell adhesion and migration; altered
fibronectin expression may facilitate ectopic implant attachment and invasion.

For a supervisor compound action proposal: women carrying the risk allele at rs12700667 (AA
or AG) who also carry the risk allele at rs7521902 (WNT4 locus) may represent a subgroup
with meaningfully higher cumulative endometriosis risk. If both loci show risk alleles,
the combined recommendation would be earlier and more aggressive specialist referral for
pelvic pain symptoms, and proactive fertility counseling by age 30. Evidence level: moderate
(consistent direction across GWAS studies, no formal gene-gene interaction paper).